Infectious diseases caused by bacteria are pathogenic bacteria invading the body to produce multiple kinds of problems-from very mild to extremely dangerous and even life-threatening.
Almost any part of the human body can be involved, such as respiratory infections; infections involving the gastrointestinal system, the skin, or urinary tract.
Common bacterial infections include tuberculosis, streptococcal pharyngitis, pneumonia, meningitis, and urinary tract infections.
Others invade the host in different manners, either through direct contact with an infected individual, ingestion by contaminated food and water, respiratory droplets from airborne bacteria, or the contamination of surfaces.
While some, such as Mycobacterium tuberculosis, are very infectious and spread by the respiratory droplet route, others require physical contact or exchange of bodily fluids.
Antibiotics are the drugs used in treating bacterial infections. These work either by the killing of the bacteria or through inhibition of bacterial growth. However, improper or excessive use of antibiotics has led to the appearance of antibiotic-resistant bacteria.
These ""superbugs"" are nasty enough to be treated and a global health challenge. The disease MRSA that is methicillin-resistant Staphylococcus aurous and MDR-TB that is multidrug-resistant tuberculosis have been on the increase, complicating treatment efforts and increasing mortality.
It prevents bacterial infectious diseases through vaccination, hygiene, safe food preparation, and prevention of infection in healthcare environments.
Vaccination is available for some bacterial infections including pneumococcal infections and tetanus, reducing the incidence rate of such infections.
In this session, the world of bacterial infections and diseases will be taken through the varieties of categories of bacterial pathogens, modes of transmission, clinical symptoms, and modern-day treatment options.
Increasing problems with antibiotic resistance, new approaches against bacterial infections, and a role for new antimicrobial therapies also will be discussed.